ChromaTan, a Decrease Gwynedd, PA-based bioprocessing and biotools biomanufacturing expertise platform improvement firm, obtained a NIH IIB grant of $2M from the Nationwide Institute of Normal Medical Sciences.
The corporate intends to make use of the funds for the event and integration of its novel BioRMB™ single-use, column-free, steady-state steady counter-current elution expertise for manufacturing AAVs.
The venture goals to supply an AAV purification course of trains for at the very least 2 AAV serotypes sourced from Chromatan’s industrial companions for each seize and sharpening (empty/full separation) in addition to scale the BioRMB™ platform to each pilot and large-scale cGMP manufacturing.
ChromaTan is a bioprocessing and biotools firm that has created a novel purification system known as BioRMB™ (previously generally known as Steady Countercurrent Tangential Chromatography or CCTC). The platform has been launched in 2023, and has demonstrated enhancements in productiveness, product restoration and product high quality for a number of sorts of biologics together with gene therapies, mRNA and monoclonal antibodies.
FinSMEs
31/05/2024
